Incidence and Outcome of Coinfections with SARS-CoV-2 and Rhinovirus

被引:27
作者
Le Glass, Elisabeth [1 ]
Hoang, Van Thuan [2 ]
Boschi, Celine [1 ,3 ]
Ninove, Laetitia [1 ,4 ]
Zandotti, Christine [1 ]
Boutin, Aurelie [5 ]
Bremond, Valerie [5 ]
Dubourg, Gregory [1 ,3 ]
Ranque, Stephane [1 ,6 ]
Lagier, Jean-Christophe [1 ,3 ]
Million, Matthieu [1 ,3 ]
Fournier, Pierre-Edouard [1 ,3 ]
Drancourt, Michel [1 ,3 ]
Gautret, Philippe [1 ,6 ]
Colson, Philippe [1 ,3 ]
机构
[1] Inst Hosp Univ Mediterranee Infect, 19-21 Blvd Jean Moulin, F-13385 Marseille, France
[2] Thai Binh Univ Med & Pharm, Thai Binh 410000, Vietnam
[3] Aix Marseille Univ, IRD, AP HM, MEPHI, 27 Blvd Jean Moulin, F-13005 Marseille, France
[4] Aix Marseille Univ, IRD 190, Inserm 1207, 27 Blvd Jean Moulin, F-13005 Marseille, France
[5] CHU Timone, Assistance Publ Hop Marseille, Serv Urgences Pediat, 264 Rue St Pierre, F-13005 Marseille, France
[6] Aix Marseille Univ, IRD, AP HM, SSA,VITROME, 27 Blvd Jean Moulin, F-13005 Marseille, France
来源
VIRUSES-BASEL | 2021年 / 13卷 / 12期
关键词
SARS-CoV-2; COVID-19; rhinovirus; coinfection; severity; COVID-19;
D O I
10.3390/v13122528
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: We aimed to compare the clinical severity in patients who were coinfected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and rhinovirus or monoinfected with a single one of these viruses. Methods: The study period ranged from 1 March 2020 to 28 February 2021 (one year). SARS-CoV-2 and other respiratory viruses were identified by real-time reverse-transcription-PCR as part of the routine work at Marseille University hospitals. Bacterial and fungal infections were detected by standard methods. Clinical data were retrospectively collected from medical files. This study was approved by the ethical committee of our institute. Results: A total of 6034/15,157 (40%) tested patients were positive for at least one respiratory virus. Ninety-three (4.3%) SARS-CoV-2-infected patients were coinfected with another respiratory virus, with rhinovirus being the most frequent (62/93, 67%). Patients coinfected with SARS-CoV-2 and rhinovirus were significantly more likely to report a cough than those with SARS-CoV-2 monoinfection (62% vs. 31%; p = 0.0008). In addition, they were also significantly more likely to report dyspnea than patients with rhinovirus monoinfection (45% vs. 36%; p = 0.02). They were also more likely to be transferred to an intensive care unit and to die than patients with rhinovirus monoinfection (16% vs. 5% and 7% vs. 2%, respectively) but these differences were not statistically significant. Conclusions: A close surveillance and investigation of the co-incidence and interactions of SARS-CoV-2 and other respiratory viruses is needed. The possible higher risk of increased clinical severity in SARS-CoV-2-positive patients coinfected with rhinovirus warrants further large scale studies.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] SARS-CoV-2 variants: Impact on biological and clinical outcome
    Mahilkar, Shakuntala
    Agrawal, Sachee
    Chaudhary, Sakshi
    Parikh, Swapneil
    Sonkar, Subash C.
    Verma, Dileep Kumar
    Chitalia, Vidushi
    Mehta, Divya
    Koner, Bidhan Chandra
    Vijay, Neetu
    Shastri, Jayanthi
    Sunil, Sujatha
    FRONTIERS IN MEDICINE, 2022, 9
  • [32] Fatal outcome in coinfection by Aggregatibacter aphrophilus and SARS-CoV-2
    Lopez, Mauro
    Vazquez, Mariana
    Torano, Paula
    Izquierdo, Hector
    Tkach, Agustina
    ACTA BIOQUIMICA CLINICA LATINOAMERICANA, 2023, 57 (04): : 403 - 406
  • [33] SARS-CoV-2 associated viral encephalitis with mortality outcome
    Azab, Mohammed A.
    Azzam, Ahmed Y.
    INTERDISCIPLINARY NEUROSURGERY-ADVANCED TECHNIQUES AND CASE MANAGEMENT, 2021, 25
  • [34] Detection of SARS-CoV-2 by Use of the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays
    Moran, Angelica
    Beavis, Kathleen G.
    Matushek, Scott M.
    Ciaglia, Carol
    Francois, Nina
    Tesic, Vera
    Love, Nedra
    JOURNAL OF CLINICAL MICROBIOLOGY, 2020, 58 (08)
  • [35] Characteristics and Outcome of SARS-CoV-2 Infection in Cancer Patients
    Basse, Clemence
    Diakite, Sarah
    Servois, Vincent
    Frelaut, Maxime
    Noret, Aurelien
    Bellesoeur, Audrey
    Moreau, Pauline
    Massiani, Marie-Ange
    Bouyer, Anne-Sophie
    Vuagnat, Perrine
    Malak, Sandra
    Bidard, Francois-Clement
    Vanjak, Dominique
    Kriegel, Irene
    Burnod, Alexis
    Bilger, Geoffroy
    Ramtohul, Toulsie
    Dhonneur, Gilles
    Bouleuc, Carole
    Cassoux, Nathalie
    Paoletti, Xavier
    Bozec, Laurence
    Cottu, Paul
    JNCI CANCER SPECTRUM, 2021, 5 (01)
  • [36] Immunological responses in SARS-CoV-2 and HIV co-infection versus SARS-CoV-2 mono-infection: case report of the interplay between SARS-CoV-2 and HIV
    Shima Shahbaz
    Wendy Sligl
    Mohammed Osman
    Shokrollah Elahi
    Allergy, Asthma & Clinical Immunology, 19
  • [37] In Silico Study of Two Linear Furanocoumarins for Dual Inhibition of Human Rhinovirus and SARS-CoV-2
    Mountessou, Bel Youssouf G.
    Mbah, Maraf B.
    Wandji, Nadine T.
    Akintemi, Eric O.
    Stammler, Hans-Georg
    Kouam, Simeon F.
    Mbouombouo, Ibrahim N.
    Singh, Thishana
    CHEMISTRYSELECT, 2025, 10 (05):
  • [38] Role of diabetes mellitus in the clinical course and outcome of SARS-CoV-2 infected patients
    Maltezou, Helena C.
    Pavli, Androula
    Tsonou, Paraskevi
    Balaska, Asimina
    Raftopoulos, Vasilios
    Papadima, Kalliopi
    Andreopoulou, Anastasia
    Tentolouris, Anastasios
    Gamaletsou, Maria N.
    Sipsas, Nikolaos, V
    Tentolouris, Nikolaos
    HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2022, 21 (02): : 221 - 227
  • [39] Immunological responses in SARS-CoV-2 and HIV co-infection versus SARS-CoV-2 mono-infection: case report of the interplay between SARS-CoV-2 and HIV
    Shahbaz, Shima
    Sligl, Wendy
    Osman, Mohammed
    Elahi, Shokrollah
    ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2023, 19 (01)
  • [40] Autoimmune response after SARS-CoV-2 infection and SARS-CoV-2 vaccines
    Hromic-Jahjefendic, Altijana
    Lundstrom, Kenneth
    Adilovic, Muhamed
    Aljabali, Alaa A. A.
    Tambuwala, Murtaza M.
    Serrano-Aroca, Angel
    Uversky, Vladimir N.
    AUTOIMMUNITY REVIEWS, 2024, 23 (03)